Patents by Inventor Richard Huang

Richard Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210178403
    Abstract: The invention features devices and methods for the deterministic separation of particles. Exemplary methods include the enrichment of a sample in a desired particle or the alteration of a desired particle in the device. The devices and methods are advantageously employed to enrich for rare cells, e.g., fetal cells, present in a sample, e.g., maternal blood and rare cell components, e.g., fetal cell nuclei. The invention further provides a method for preferentially lysing cells of interest in a sample, e.g., to extract clinical information from a cellular component, e.g., a nucleus, of the cells of interest. In general, the method employs differential lysis between the cells of interest and other cells (e.g., other nucleated cells) in the sample.
    Type: Application
    Filed: September 15, 2020
    Publication date: June 17, 2021
    Inventors: Lotien Richard Huang, Thomas A. Barber, Bruce L. Carvalho, Ravi Kapur, Paul Vernucci, Mehmet Toner, Zihua Wang
  • Patent number: 10856568
    Abstract: A device including a water chamber for filtering smoke or vapor prior to inhalation of the smoke or vapor. The device including a vaporization chamber that contains a substance to be heated or burned. The device including an air flow chamber, herein the air flow chamber connects the vaporization chamber, wherein the air flow chamber is configured to provide a tunnel between an upper edge and a lower edge of the air flow chamber, for passage of air/vapor from an air/vapor entry port to a filtered air exit port for air/vapor at the water chamber, in a snake like manner; wherein the air/vapor entry port is located at a point where the vaporization chamber is joined to the water chamber. The air flow chamber is configured to prevent leakage of water from the water chamber to the vaporization chamber.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: December 8, 2020
    Inventor: Yao Tien Richard Huang
  • Patent number: 10805275
    Abstract: A method in an internet server for implementing internet service, the method including exclusively binding a first socket handle object of a first process with a first port. The method also includes generating a first child process from the first process and creating a first duplicate socket handle of the first socket handle object in a first file, the first file being associated with an id of the first child process. The method further includes forming, using the first child process, a first child socket handle object from the first duplicate socket handle in the first file, thereby causing the first child socket handle object to be associated with the first port.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: October 13, 2020
    Assignee: Trend Micro Incorporated
    Inventor: Hua-Lung Richard Huang
  • Patent number: 10786817
    Abstract: The invention features devices and methods for the deterministic separation of particles. Exemplary methods include the enrichment of a sample in a desired particle or the alteration of a desired particle in the device. The devices and methods are advantageously employed to enrich for rare cells, e.g., fetal cells, present in a sample, e.g., maternal blood and rare cell components, e.g., fetal cell nuclei. The invention further provides a method for preferentially lysing cells of interest in a sample, e.g., to extract clinical information from a cellular component, e.g., a nucleus, of the cells of interest. In general, the method employs differential lysis between the cells of interest and other cells (e.g., other nucleated cells) in the sample.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: September 29, 2020
    Assignees: The General Hospital Corporation, GPB Scientific, LLC
    Inventors: Lotien Richard Huang, Thomas A. Barber, Bruce L. Carvalho, Ravi Kapur, Paul Vernucci, Mehmet Toner, Zihua Wang
  • Patent number: 10757955
    Abstract: Included in the present invention are a method for preparing tealeaf extracts having different tastes, and a beverage prepared using extracts made by the method. The method involves adding tealeaves to an extraction column, performing continuous extraction using water at 5° C.-140° C. at a flow rate of 20-200 mL/min, collecting liquid extracts in sections, and drawing a relative taste intensity curve; and according to a taste variation shown in the relative taste intensity curve, recombining collected liquid extracts of different sections. The method of the present invention can produce tealeaf extracts having high grade taste and high concentration without the need for a concentration step, the extraction yield is high, and the sensory attributes of the tealeaf extracts can be rebalanced in a very flexible manner, so as to obtain beverages of different tastes.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: September 1, 2020
    Assignee: THE COCA-COLA COMPANY
    Inventors: Xiaogen Yang, Gooden Wei, Richard Huang, Amy Song
  • Publication number: 20200210560
    Abstract: A system for a dynamically evolving cognitive architecture for the development of a secure key and confidence level based data derived from biometric sensors and a user's behavioral activities. The system comprises one or more processors, one or more sensors, one or more databases, and non-transitory computer readable memory. The non-transitory computer readable memory comprises a plurality of executable instructions wherein the instructions, when executed by the one or more processors, cause the one or more processors to process operations comprising creating a set of policies based on user data sets and inputs, creating a faceted classification, establishing a Trust Level, processing sensor data, comparing data to one or more databases, correlating data, updating Trust Levels, updating security keys, and storing the keys in memory. In certain embodiments, the stored data is used to create a usage schema independent from a user's actual identity.
    Type: Application
    Filed: December 23, 2019
    Publication date: July 2, 2020
    Inventors: Samuel Yan, S. Keith Muma, Richard Huang, Dan Alan Preston, Trinitie Marie Vance
  • Publication number: 20200190186
    Abstract: Provided herein are antibodies, or antigen-binding portions thereof, that bind to T-cell immunoglobulin and mucin-domain containing-3 (TIM3) protein. Also provided are uses of these antibodies, or antigen-binding portions thereof, in therapeutic applications, such as treatment of cancer. Further provided are cells that produce the antibodies, or antigen-binding portions thereof, polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof, and vectors comprising the polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof.
    Type: Application
    Filed: November 27, 2019
    Publication date: June 18, 2020
    Applicant: Bristol-Myers Squibb Company
    Inventors: Xiao Min SCHEBYE, Mark J. SELBY, Michelle Minhua HAN, Christine BEE, Andy X. DENG, Anan CHUNTHARAPAI, Brigitte DEVAUX, Huiming LI, Paul O. SHEPPARD, Alan J. KORMAN, Daniel F. ARDOUREL, Ekaterina DEYANOVA, Richard HUANG, Guodong CHEN, Michelle KUHNE, Hong-An TRUONG
  • Publication number: 20200115463
    Abstract: Provided herein are antibodies, or antigen binding portions thereof, that bind to glucocorticoid-inducible TNF receptor (GITR). Also provided are uses of these proteins in therapeutic applications, such as in the treatment of cancer. Further provided are cells that produce the antibodies, polynucleotides encoding the heavy and/or light chain variable region of the antibodies, and vectors comprising the polynucleotides encoding the heavy and/or light chain variable region of the antibodies.
    Type: Application
    Filed: October 25, 2019
    Publication date: April 16, 2020
    Inventors: Changyu WANG, Nils LONBERG, Alan J. KORMAN, Mark J. SELBY, Mohan SRINIVASAN, Karla A. HENNING, Michelle Minhua HAN, Guodong CHEN, Richard HUANG, Indrani CHAKRABORTY, Haichun HUANG, Susan WONG, Huiming LI
  • Publication number: 20200079865
    Abstract: Provided herein are antibodies, or antigen binding portions thereof, that bind to glucocorticoid-inducible TNF receptor (GITR). Also provided are uses of these proteins in therapeutic applications, such as in the treatment of cancer. Further provided are cells that produce the antibodies, polynucleotides encoding the heavy and/or light chain variable region of the antibodies, and vectors comprising the polynucleotides encoding the heavy and/or light chain variable region of the antibodies.
    Type: Application
    Filed: September 23, 2019
    Publication date: March 12, 2020
    Inventors: Changyu WANG, Nils LONBERG, Alan J. KORMAN, Mark J. SELBY, Mohan SRINIVASAN, Karla HENNING, Michelle Minhua HAN, Guodong CHEN, Richard HUANG, Indrani CHAKRABORTY, Haichun HUANG, Susan WONG, Huiming LI
  • Patent number: 10572640
    Abstract: A system for a dynamically evolving cognitive architecture for the development of a secure key and confidence level based data derived from biometric sensors and a user's behavioral activities. The system comprises one or more processors, one or more sensors, one or more databases, and non-transitory computer readable memory. The non-transitory computer readable memory comprises a plurality of executable instructions wherein the instructions, when executed by the one or more processors, cause the one or more processors to process operations comprising creating a set of policies based on user data sets and inputs, creating a faceted classification, establishing a Trust Level, processing sensor data, comparing data to one or more databases, correlating data, updating Trust Levels, updating security keys, and storing the keys in memory. In certain embodiments, the stored data is used to create a usage schema independent from a user's actual identity.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: February 25, 2020
    Assignee: Personnus
    Inventors: Samuel Yan, S. Keith Muma, Richard Huang, Dan Alan Preston, Trinitie Marie Vance
  • Patent number: 10533052
    Abstract: Provided herein are antibodies, or antigen-binding portions thereof, that bind to T-cell immunoglobulin and mucin-domain containing-3 (TIM3) protein. Also provided are uses of these antibodies, or antigen-binding portions thereof, in therapeutic applications, such as treatment of cancer. Further provided are cells that produce the antibodies, or antigen-binding portions thereof, polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof, and vectors comprising the polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof.
    Type: Grant
    Filed: June 25, 2018
    Date of Patent: January 14, 2020
    Assignee: Bristol-Myers Squibb Company
    Inventors: Xiao Min Schebye, Mark J. Selby, Michelle Minhua Han, Christine Bee, Andy X. Deng, Anan Chuntharapai, Brigitte Devaux, Huiming Li, Paul O. Sheppard, Alan J. Korman, Daniel F. Ardourel, Ekaterina Deyanova, Richard Huang, Guodong Chen, Michelle Kuhne, Hong-An Truong
  • Patent number: 10501550
    Abstract: Provided herein are antibodies, or antigen binding portions thereof, that bind to glucocorticoid-inducible TNF receptor (GITR). Also provided are uses of these proteins in therapeutic applications, such as in the treatment of cancer. Further provided are cells that produce antibodies, polynucleotides encoding the heavy and/or light chain variable region of the antibodies, and vectors comprising the polynucleotides encoding the heavy and/or light chain variable region of the antibodies.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: December 10, 2019
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Changyu Wang, Nils Lonberg, Alan J. Korman, Mark J. Selby, Mohan Srinivasan, Karla A. Henning, Michelle Minhua Han, Guodong Chen, Richard Huang, Indrani Chakraborty, Haichun Huang, Susan Wong, Huiming Li
  • Patent number: 10465010
    Abstract: Provided herein are antibodies, or antigen binding portions thereof, that bind to glucocorticoid-inducible TNF receptor (GITR). Also provided are uses of these proteins in therapeutic applications, such as in the treatment of cancer. Further provided are cells that produce the antibodies, polynucleotides encoding the heavy and/or light chain variable region of the antibodies, and vectors comprising the polynucleotides encoding the heavy and/or light chain variable region of the antibodies.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: November 5, 2019
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Changyu Wang, Nils Lonberg, Alan J. Korman, Mark J. Selby, Mohan Srinivasan, Karla Henning, Michelle Minhua Han, Guodong Chen, Richard Huang, Indrani Chakraborty, Haichun Huang, Susan Wong, Huiming Li
  • Patent number: 10394293
    Abstract: A method for providing over-heating protection of a target device within an information processing system is disclosed. A determination is made whether or not a power status of the information processing system is set to turn on a main power of a power supply device. If the power status of the information processing system is set to turn on a main power of a power supply device, a power switch of the target device is turned on; otherwise, another determining is made whether or not the target device is set to operate based on a user's setting. If the target device is set to operate based on the user's setting, the power switch of the target device is turned on; otherwise, the power switch of the target device is turned off.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: August 27, 2019
    Assignee: Lenovo Enterprise Solutions (Singapore) Pte. Ltd.
    Inventors: Himansu S. Das, Steven C. Chou, Richard Huang, Jeff Lin
  • Publication number: 20190164929
    Abstract: In an embodiment, a system includes: a circular frame comprising a first side and a second side opposite the first side, wherein the circular frame comprises an aperture formed therethrough; an insert disposed within the aperture; a first wafer disposed over the insert; a second wafer disposed over the first wafer, wherein both the first wafer and the second wafer are configured for eutectic bonding when heated; two clamps disposed on the first side along the circular frame, wherein the two clamps are configured to contact the second wafer at respective clamp locations; and a plurality of pieces configured to secure the insert within the aperture, the plurality of pieces comprising both fixed and flexible pieces, the plurality of pieces comprising two fixed pieces disposed respectively adjacent to the clamp locations along the second side of the circular frame.
    Type: Application
    Filed: November 28, 2018
    Publication date: May 30, 2019
    Inventors: Chih-Hang Chang, Richard Huang, I-Shi Wang, Yin-Tun Chou, Jen-Hao Liu
  • Patent number: 10175376
    Abstract: Provided is an apparatus, system, and method for detecting a metal contaminant in a sensor-enabled dose form. According to the method, a sensor-enabled dose form is oriented in a predetermined orientation. The sensor-enabled dose form is received through an aperture of a metal detector. A detection signal is generated by the metal detector in response to receiving the sensor-enabled dose form through the aperture of the metal detector. The detection signal is compared to a predetermined threshold. The presence of a metal contaminant in the sensor-enabled dose form is determined based on the comparison of the detection signal and the predetermined threshold. In another method, the sensor-enabled dose form is first oriented in a first orientation and then in a second orientation. The apparatus includes a guide, a metal detector, and a comparator circuit. The system further includes a controller to reject contaminated sensor-enabled dose forms.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: January 8, 2019
    Assignee: PROTEUS DIGITAL HEALTH, INC.
    Inventors: Raymond Schmidt, Patricia Johnson, Maria Holen, Richard Huang, Alvin Thai
  • Publication number: 20190001344
    Abstract: The invention features devices and methods for the deterministic separation of particles. Exemplary methods include the enrichment of a sample in a desired particle or the alteration of a desired particle in the device. The devices and methods are advantageously employed to enrich for rare cells, e.g., fetal cells, present in a sample, e.g., maternal blood and rare cell components, e.g., fetal cell nuclei. The invention further provides a method for preferentially lysing cells of interest in a sample, e.g., to extract clinical information from a cellular component, e.g., a nucleus, of the cells of interest. In general, the method employs differential lysis between the cells of interest and other cells (e.g., other nucleated cells) in the sample.
    Type: Application
    Filed: April 27, 2018
    Publication date: January 3, 2019
    Inventors: Lotien Richard Huang, Thomas A. Barber, Bruce L. Carvalho, Ravi Kapur, Paul Vernucci, Mehmet Toner, Zihua Wang
  • Publication number: 20180339042
    Abstract: Provided herein are antibodies, or antigen binding portions thereof, that bind to glucocorticoid-inducible TNF receptor (GITR). Also provided are uses of these proteins in therapeutic applications, such as in the treatment of cancer. Further provided are cells that produce the antibodies, polynucleotides encoding the heavy and/or light chain variable region of the antibodies, and vectors comprising the polynucleotides encoding the heavy and/or light chain variable region of the antibodies.
    Type: Application
    Filed: November 17, 2016
    Publication date: November 29, 2018
    Inventors: Changyu WANG, Nils LONBERG, Alan J. KORMAN, Mark J. SELBY, Mohan SRINIVASAN, Karla A. HENNING, Michelle Minhua HAN, Guodong CHEN, Richard HUANG, Indrani CHAKRABORTY, Haichun HUANG, Susan Chien-Szu WONG, Huiming LI, Bryan C. BARNHART, Aaron P. YAMNIUK, Ming LEI, Liang SCHWEIZER, Sandra V. HATCHER, Arvind RAJPAL
  • Publication number: 20180298097
    Abstract: Provided herein are antibodies, or antigen-binding portions thereof, that bind to T-cell immunoglobulin and mucin-domain containing-3 (TIM3) protein. Also provided are uses of these antibodies, or antigen-binding portions thereof, in therapeutic applications, such as treatment of cancer. Further provided are cells that produce the antibodies, or antigen-binding portions thereof, polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof, and vectors comprising the polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof.
    Type: Application
    Filed: June 25, 2018
    Publication date: October 18, 2018
    Applicant: Bristol-Myers Squibb Company
    Inventors: Xiao Min Schebye, Mark J. Selby, Michelle Minhua Han, Christine Bee, Andy X. Deng, Anan Chuntharapai, Brigitte Devaux, Huiming Li, Paul O. Sheppard, Alan J. Korman, Daniel F,. Ardourel, Ekaterina Deyanova, Richard Huang, Guodong Chen, Michelle Kuhne, Hong-An Troung
  • Patent number: D918164
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: May 4, 2021
    Assignee: Crestron Electronics, Inc.
    Inventors: Srinivas Vunnava, Dao Phan, Michael Fonti, Richard Huang